TELIX Pharmaceuticals Ltd (TLX) — Cash Flow Quality Index
TELIX Pharmaceuticals Ltd (TLX) has a Cash Flow Quality Index of 3.04x as of June 2024. Operating cash flow of AU$35.45 Million exceeds net income of AU$11.68 Million, indicating high earnings quality where cash backs reported profits. Explore TLX long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
TELIX Pharmaceuticals Ltd Cash Flow Quality Index (2023–2024)
Historical Cash Flow Quality Index for TELIX Pharmaceuticals Ltd across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible equity quality of TELIX Pharmaceuticals Ltd to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for TELIX Pharmaceuticals Ltd (2023–2024)
Year-by-year earnings quality comparison for TELIX Pharmaceuticals Ltd. For live market cap and the full company financial profile, see TELIX Pharmaceuticals Ltd (TLX) total market value.
| Year | Quality Index | Operating CF (AUD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.86x | AU$43.03 Million | AU$49.92 Million | ▼ -81.2% |
| 2023 | 4.58x | AU$23.88 Million | AU$5.21 Million | — |